True Wealth Design’s AngioDynamics ANGO Stock Holding History

True Wealth Design’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$785	Buy	51 +1	+2%	+$15	﹤0.01%	2005
2026 Q2	$651	Buy	+50	New	+$569	﹤0.01%	2115
2026 Q1	–	Sell	-5	Closed	-$65	–	2706
2025 Q4	$65	Buy	+5	New	+$62	﹤0.01%	2392
2025 Q3	–	Sell	-8	Closed	-$80	–	2725
2025 Q2	$80	Buy	8 +2	+33%	+$20	﹤0.01%	2293
2025 Q1	$57	Buy	+6	New	+$63	﹤0.01%	2348
2024 Q4	–	Sell	-651	Closed	-$5.07K	–	1358
2024 Q3	$5.07K	Buy	+651	New	+$4.7K	﹤0.01%	552

Other funds holding ANGO

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

MNBTD

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

True Wealth Design's ANGO Position: Q3 2026 in Review

True Wealth Design increased its AngioDynamics (ANGO) stake by 2% in Q3 2026, buying an estimated $15 and bringing the position to 51 shares worth $785. The position accounts for ﹤0.01% of the portfolio, ranked #2005.

True Wealth Design first reported a position in ANGO in Q3 2024 and has held it in 6 quarters since. The position peaked at $5.07K in Q3 2024. 12 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

True Wealth Design held 51 shares of AngioDynamics worth $785 as of Q3 2026.
True Wealth Design bought 1 AngioDynamics share in Q3 2026, an estimated $15.
AngioDynamics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #2005 holding.
True Wealth Design first reported a position in AngioDynamics in Q3 2024 and has held it in 6 quarters since.
True Wealth Design's AngioDynamics position peaked at $5.07K in Q3 2024.
12 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.